Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented The Asia Group in the transaction. The Asia Group (TAG), a premier partner to the world’s leading companies...
RLH Equity Partners’ Minority Investment in The Asia Group
Cake’s $13 Million Seed Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Cake in the transaction. Cake, an open-source AI infrastructure platform, announced raising $13 million in Seed financing led...
Phantom’s Acquisition of Blowfish
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Phantom in the transaction. Phantom, developer of a crypto wallet designed for decentralized finance (Defi) and non-fungible tokens...
Zarminali Health’s $40 Million Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Zarminali Health in the transaction. Zarminali Health, the first outpatient pediatric destination purpose-built to provide seamless and coordinated...
Finix’s $75 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Finix in the transaction. Finix, a full-stack payment platform, annouced raising $75 million in Series C financing led...
Glean’s $260 Million Series E Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Altimeter, DST Global, Craft Ventures and Coatue, as investors in the transaction. Glean, an AI enterprise search startup,...
OpenAI Startup Fund and Thrive Global’s Launch of Thrive AI Health
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Thrive AI Health in the transaction. The OpenAI Startup Fund and Thrive Global announced the launch of a...
Clasp’s $1.5 Million Seed Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Clasp in the transaction. Clasp announced it has raised $1.5 million in financing led by Base10. Individual investors...
Remix Therapeutics’ Collaboration Agreement With Roche
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Remix Therapeutics in the transaction. Remix Therapeutics (Remix), a clinical stage biotechnology company, announced it had entered into...
Remix Therapeutics’ $70 Million Series B Financing
Gunderson Dettmer advised Remix Therapeutics on the deal. Remix Therapeutics, a Massachusetts-based biotech company, announced its $70 million Series B financing which included participation from Surveyor, Foresite...
Remix Therapeutics’ Collaboration Agreement with Janssen Pharmaceutica NV
Gunderson Dettmer represented Remix Therapeutics on the deal. Remix Therapeutics, a Massachusetts-based biotech company, announced its collaboration agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical...
Selfbook’s $25 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Tiger Global on the deal. Tiger Global led the $25 million Series A financing of Selfbook, a hotel...